Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity : a pharmacoeconomic evaluation in the Brazilian context

Autor: Cris Renata Grou Volpe, Raylayne Ferreira Bessa, Rodrigo Silva Suguino, Mani Indiana Funez, Démerson André Polli, Gisele Martins, Brunna Carvalho Viana Campos

Publikováno v: Repositório Institucional da UnB
Universidade de Brasília (UnB)
instacron:UNB
Brazilian Journal of Pharmaceutical Sciences; Vol. 48 No. 2 (2012); 227-236
Brazilian Journal of Pharmaceutical Sciences; Vol. 48 Núm. 2 (2012); 227-236
Brazilian Journal of Pharmaceutical Sciences; v. 48 n. 2 (2012); 227-236
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Volume: 48, Issue: 2, Pages: 227-236, Published: JUN 2012
Brazilian Journal of Pharmaceutical Sciences, Vol 48, Iss 2, Pp 227-236 (2012)

Antimuscarinic agents are the first-line choice for the treatment of neurogenic detrusor overactivity (NDO). The currently available antimuscarinic drugs have been widely studied in patients presenting idiopathic detrusor overactivity; however, inves

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0f1903bc04719cab3a5dbf197dde0af
http://repositorio.unb.br/handle/10482/11900